News
Through this agreement, Sunflower will commercially launch its Daisy Petal™ Perfusion Bioreactor System in Asia, a significant step in the company’s ongoing product commercialization.
MEDFORD, Mass., February 26, 2025--Sunflower Therapeutics announced its first distribution agreement with PharmNXT Biotech to launch its Daisy Petal Perfusion Bioreactor System in Asia. MEDFORD, Mass.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback